Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Dermatology|February 27, 2024
Demographics, clinical characteristics, and treatment patterns among keloid patients: United States Electronic Health Records (EHR) Database StudyAbisola Olopoenia, Yuji Yamaguchi, Elena Peeva, et al.
BMC Pulmonary Medicine|August 17, 2024
Treatment patterns in patients with newly diagnosed COPD in the USAAntonio Anzueto, Sheri Rogers, Bonnie Donato, et al.
Pain Management|October 19, 2020
Chronic non-cancer pain and its association with healthcare use and costs among individuals with obstructive sleep apneaAakash Bipin Gandhi, Julia F Slejko, Ester Villalonga-Olives, et al.
Lancet Regional Health. Americas|February 13, 2023
Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: A nested case-control studyAbisola Olopoenia, Wendy Camelo-Castillo, Danya M Qato, et al.
Drug and Alcohol Dependence|November 30, 2021
Patterns of opioid and benzodiazepine use with gabapentin among disabled Medicare beneficiaries - A retrospective cohort studyAbisola Olopoenia, Wendy Camelo-Castillo, Danya M Qato, et al.
Pain|May 27, 2020
Patterns of prescription opioid utilization among adolescents and adults with comorbid chronic pain and mental health diagnosisAbisola Olopoenia, Eberechukwu Onukwugha, Linda Simoni-Wastila, et al.
Journal of Clinical Medicine|March 29, 2023
The Associations between Insomnia Severity and Health Outcomes in the United StatesFrançois-Xavier Chalet, Paul Saskin, Ajay Ahuja, et al.
Journal of Affective Disorders|May 16, 2025
Examining the burden of major depressive disorder with moderate-to-severe insomnia symptoms in five European countriesJesper Gottorp Riise, M Janelle Cambron-Mellott, Zhiheng Zhang, et al.
Pharmacoeconomics - Open|January 26, 2023
Mapping the Insomnia Severity Index Instrument to EQ-5D Health State Utilities: A United Kingdom PerspectiveFrançois-Xavier Chalet, Teodora Bujaroska, Evi Germeni, et al.
Kidney Medicine|April 17, 2025
Effectiveness of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in US Clinical Practice With Comparison to Historical Control DataRonald D Perrone, Diana Garbinsky, Sasikiran Nunna, et al.
Pageof 2